Skip to content

Non-pharmacological treatment in generalized osteoarthritis.

A randomized superiority trial investigating non-pharmacological care for patients with generalized osteoarthritis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26708
Enrollment
160
Registered
2009-12-09
Start date
2010-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized osteoarthritis, Polyarticular arthritis, Randomized clinical trial, Multi-disciplinary therapy, Telephone

Interventions

Experimental intervention: The intervention lasts 6 weeks (max 8 persons per group), consists of 7 meetings, and aims improve the patients health related quality of life by optimising the current lif
Advising the patient based upon personal health risks
Agreeing with the patient on a realistic set of goals
Assisting to anticipate barriers and develop a specific action plan
and Arranging follow-up support. An example, a participant wears a pedometer to elicit his/her physical activity level (A1). Together with the health care provider, the patient discusses the outcome (

Sponsors

Sint Maartenskliniek Department of reumatology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Men and women are eligible to enter the trial if they are: 1. 18 years or older; 2. Diagnosed with GOA; 3. Properly motivated for changing lifestyle; 4. Willing to participate in a group; 5. Able to comply on the planned time schedule of both treatment conditions.

Exclusion criteria

Exclusion criteria: Patients are excluded when they: 1. Are awaiting surgery; 2. Already participated, unsuccessfully, in a self-management program; 3. Are suspected of high levels of distress; 4. Are illiterate; 5. Are not capable of communicating in Dutch; 6. Can't come to the hospital.

Design outcomes

Primary

MeasureTime frame
Daily functioning: Health Assessment Questionnaire (HAQ); Minimal Important Change: 0.26; Time points: first year after treatment. 1. Specific functioning: Patient specific complaints questionnaire (PSK); 2. Quality of life: RAND-36; 3. Fatigue: Checklist Individual Strength (CIS). Time points for all abovementioned variables are: 6 weeks, 6 months, 1 year after baseline.

Secondary

MeasureTime frame
Costs: Questionnaire and diary. Time points for all abovementioned variables are: 6 weeks, 3 months, 6 months, 9 months, 1 year after baseline.

Contacts

Public ContactThomas Hoogeboom

Postbus 9011

t.hoogeboom@maartenskliniek.nl+31 (0)24 327 2718

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)